Nathalie Labarriere
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
The orphan receptor GPR84 drives inflammation in Buruli ulcer development.
Journal: Science translational medicine
Published: April 15, 2026
PD-1 and TIGIT coexpression enables selective enrichment of clonally expanded tumor-reactive CD8 T cells for melanoma TIL therapy.
Journal: Journal of translational medicine
Published: April 15, 2026
TAP1 deficiency reshapes tumor antigenicity and enables CD8 T cell targeting in colorectal cancer.
Journal: Molecular therapy. Oncology
Published: January 28, 2026
Systematic identification of lincRNA-derived immunogenic peptides in melanoma.
Journal: Oncoimmunology
Published: August 02, 2025
Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes.
Journal: Oncoimmunology
Published: July 10, 2024
STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma.
Journal: Clinical and translational medicine
Published: April 08, 2024
Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity.
Journal: Molecular therapy. Oncology
Published: June 28, 2023
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Journal: Science (New York, N.Y.)
Published: June 08, 2023
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells.
Journal: Cancer immunology, immunotherapy : CII
Published: September 12, 2022
Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.
Journal: Frontiers in immunology
Published: May 09, 2022
The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles.
Journal: Frontiers in immunology
Published: April 21, 2022
Last Updated: 09/26/2026